NYSE : EFOR
Everforth, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 37.01 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.51B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.54B |
| Enterprise Value | 2.85B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 41.10M |
| Shares Outstanding | 41.10M |
| Shares Change (YoY) | -5.94% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 3.70% |
| Owned by Institutions (%) | 102.45% |
| Float | 37.45M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 22.94 |
| Forward PE | 9.12 |
| PS Ratio | 0.39 |
| Forward PS | 0.38 |
| PB Ratio | 0.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.88 |
| P/OCF Ratio | 6.65 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 41.97 |
| EV / Sales | 0.72 |
| EV / EBITDA | 8.52 |
| EV / EBIT | 12.54 |
| EV / FCF | 14.59 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.13 |
| Quick Ratio | 2.00 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | 3.97 |
| Debt / FCF | 7.46 |
| Interest Coverage | 3.06 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 3.70% |
| Return on Assets (ROA) | 3.68% |
| Return on Invested Capital (ROIC) | 4.58% |
| Return on Capital Employed (ROCE) | 6.40% |
| Weighted Average Cost of Capital (WACC) | 4.97% |
| Revenue Per Employee | $1.42M |
| Profits Per Employee | $24,286 |
| Employee Count | 2,800 |
| Asset Turnover | 1.03 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 39.20M |
| Effective Tax Rate | 36.57% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -16.22% |
| 50-Day Moving Average | 34.91 |
| 200-Day Moving Average | 32.01 |
| Relative Strength Index (RSI) | 50.32 |
| Average Volume (20 Days) | 718,855 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.38M |
| Short Previous Month | 3.63M |
| Short % of Shares Out | 8.23% |
| Short % of Float | 9.03% |
| Short Ratio (days to cover) | 4.85 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.99B |
| Gross Profit | 1.13B |
| Operating Income | 227.60M |
| Pretax Income | 107.20M |
| Net Income | 68.00M |
| EBITDA | 334.80M |
| EBIT | 227.60M |
| Earnings Per Share (EPS) | $1.63 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 147.50M |
| Total Debt | 1.46B |
| Net Cash | -1.31B |
| Net Cash Per Share | -$31.93 |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 44.87 |
| Working Capital | 528.50M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 231.70M |
| Capital Expenditures | -36.10M |
| Depreciation & Amortization | 107.20M |
| Net Borrowing | 220.80M |
| Free Cash Flow | 195.60M |
| FCF Per Share | $4.76 |
Margins
| Measure | Value |
|---|
| Gross Margin | 28.25% |
| Operating Margin | 5.71% |
| Pretax Margin | 2.69% |
| Profit Margin | 1.71% |
| EBITDA Margin | 8.40% |
| EBIT Margin | 5.71% |
| FCF Margin | 4.91% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 5.94% |
| Shareholder Yield | 5.94% |
| Earnings Yield | 4.36% |
| FCF Yield | 12.69% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $38.50 |
| Price Target Difference | 2.67% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 2.37% |
| EPS Growth Forecast (3Y) | 4.60% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 4, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.13 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |